Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico
| Ano de defesa: | 2017 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Tese |
| Tipo de acesso: | Acesso aberto |
| dARK ID: | ark:/26339/001300000jx1c |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Santa Maria
Brasil Bioquímica UFSM Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica Centro de Ciências Naturais e Exatas |
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Não Informado pela instituição
|
| Palavras-chave em Português: | |
| Link de acesso: | http://repositorio.ufsm.br/handle/1/17975 |
Resumo: | Traumatic brain injury (TBI) is a multipathology associated to severe physiological changes that result in an unfavorable socioeconomic impact in a worldwide. Its pathophysiology comprises excitotoxicity, mitochondrial dysfunction and inflammatory processes leading to cells death in the central nervous system. Consequently, cognitive changes converge to clinical manifestations, such as behavioral deficits and the appearance of neurodegenerative processes. In experimental models of TBI many promising drugs reported failures when clinically tested, largely because of their effects on a single system. Thus, it is sought to study new therapeutic alternatives such as Guanosine (GUO), an endogenous purinergic nucleoside. At present, attention has been paid to its neuroprotective effects, since it reduces neurotoxic and degenerative events in several experimental models in vivo and in vitro. In this context, the objective of this thesis was to evaluate the possible effects of GUO on the acute and chronic alterations caused by TBI and in a model of excitotoxicity in rodents. The action of purinergic nucleoside was investigated in different experimental models and the results divided into one scientific paper and two manuscripts. The results of article 1 demonstrated the neuroprotective action of GUO against the acute effects observed in the secondary cascade 3h post-trauma. The imbalance in mitochondrial activity and the redox system in TBI model, were reduced by GUO in cerebral structures. At the same time, we can note the effectiveness of GUO in the maintenance of Ca2+ homeostasis modified after TBI. This effect reveals the relationship between the restoration of mitochondrial activity and the maintenance of the glutamatergic system produced by GUO. In manuscript 1, the study focuses on assessing the relationship of behavioral and morphological chronic changes triggered by TBI (for 21 days), as well as the potential action of GUO. Regarding the comorbidities referenced in this experimental model, we observed an increase in the anxiety-like behavior of animals, accompanied by impairments in cognitive function. Its corroborates with the alterations found in the expression of proteins related to the processes of plasticity and synaptic repair in the hippocampus. In this way, hippocampus damage is characterized by an increase of neuron cell death, astrogliosis and reactive microgliosis 21 days after TBI. Chronic treatment with GUO conferred neuroprotection against these parameters, but the A1 adenosine receptor antagonist blocked this effect. In manuscript 2, the study focused on evaluating possible targets of the pharmacological action of GUO in a model of excitotoxicity. Across electrophysiological tools, it can be confirmed the protective effect of GUO against excitotoxicity, through the astrocytic function. In this context, it was found that the homeostasis of calcium (Ca2+) is essential for its activity and this neuroprotection effect is not only dependent on the Ca2+ or potassium (K+) channel activity. Moreover, it was observed that GUO established its protective effect by regulating adenosine levels and modulating P2 (P2Y1) receptors rather than a direct binding with adenosinergic receptors. In this way, this thesis characterized the neuroprotective effect of GUO against acute and chronic damages caused by TBI as well as the possible mechanisms of action involved. |
| id |
UFSM_b8de116065bf46f2f1249de821203857 |
|---|---|
| oai_identifier_str |
oai:repositorio.ufsm.br:1/17975 |
| network_acronym_str |
UFSM |
| network_name_str |
Manancial - Repositório Digital da UFSM |
| repository_id_str |
|
| spelling |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgicoEffect of guanosine against acute and chronic damage caused by traumatic brain injury: a new perspective involving the purinergic systemTraumatismo crânio encefálicoExcitotoxicidadeGuanosinaSistema purinérgicoAvaliação comportamentalEletrofisiologiaTraumatic brain injuryExcitotoxicityGuanosinePurinergic systemBehavioral evaluationElectrophysiologyCNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICATraumatic brain injury (TBI) is a multipathology associated to severe physiological changes that result in an unfavorable socioeconomic impact in a worldwide. Its pathophysiology comprises excitotoxicity, mitochondrial dysfunction and inflammatory processes leading to cells death in the central nervous system. Consequently, cognitive changes converge to clinical manifestations, such as behavioral deficits and the appearance of neurodegenerative processes. In experimental models of TBI many promising drugs reported failures when clinically tested, largely because of their effects on a single system. Thus, it is sought to study new therapeutic alternatives such as Guanosine (GUO), an endogenous purinergic nucleoside. At present, attention has been paid to its neuroprotective effects, since it reduces neurotoxic and degenerative events in several experimental models in vivo and in vitro. In this context, the objective of this thesis was to evaluate the possible effects of GUO on the acute and chronic alterations caused by TBI and in a model of excitotoxicity in rodents. The action of purinergic nucleoside was investigated in different experimental models and the results divided into one scientific paper and two manuscripts. The results of article 1 demonstrated the neuroprotective action of GUO against the acute effects observed in the secondary cascade 3h post-trauma. The imbalance in mitochondrial activity and the redox system in TBI model, were reduced by GUO in cerebral structures. At the same time, we can note the effectiveness of GUO in the maintenance of Ca2+ homeostasis modified after TBI. This effect reveals the relationship between the restoration of mitochondrial activity and the maintenance of the glutamatergic system produced by GUO. In manuscript 1, the study focuses on assessing the relationship of behavioral and morphological chronic changes triggered by TBI (for 21 days), as well as the potential action of GUO. Regarding the comorbidities referenced in this experimental model, we observed an increase in the anxiety-like behavior of animals, accompanied by impairments in cognitive function. Its corroborates with the alterations found in the expression of proteins related to the processes of plasticity and synaptic repair in the hippocampus. In this way, hippocampus damage is characterized by an increase of neuron cell death, astrogliosis and reactive microgliosis 21 days after TBI. Chronic treatment with GUO conferred neuroprotection against these parameters, but the A1 adenosine receptor antagonist blocked this effect. In manuscript 2, the study focused on evaluating possible targets of the pharmacological action of GUO in a model of excitotoxicity. Across electrophysiological tools, it can be confirmed the protective effect of GUO against excitotoxicity, through the astrocytic function. In this context, it was found that the homeostasis of calcium (Ca2+) is essential for its activity and this neuroprotection effect is not only dependent on the Ca2+ or potassium (K+) channel activity. Moreover, it was observed that GUO established its protective effect by regulating adenosine levels and modulating P2 (P2Y1) receptors rather than a direct binding with adenosinergic receptors. In this way, this thesis characterized the neuroprotective effect of GUO against acute and chronic damages caused by TBI as well as the possible mechanisms of action involved.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESO traumatismo cranioencefálico (TCE) é uma patologia multifatorial associada a graves alterações fisiológicas que resultam em um impacto socioeconômico desfavorável a nível mundial. Sua fisiopatologia compreende a excitotoxicidade, disfunção mitocondrial e processos inflamatórios que conduzem a morte de células do sistema nervoso central. Consequentemente, essas alterações convergem a manifestações clínicas, como déficits comportamentais e o aparecimento de processos neurodegenerativos. Em modelos experimentais de TCE muitas drogas promissoras reportaram falhas quando testadas clinicamente, muito devido aos seus efeitos localizados em um único sistema. Desde modo, busca-se estudar novas alternativas terapêuticas como a Guanosina (GUO), um nucleosídeo purinérgico endógeno. Atualmente, tem sido dedicada atenção aos seus efeitos neuroprotetores, uma vez que reduz eventos neurotóxicos e degenerativos em diversos modelos experimentais in vivo e in vitro. Nesse contexto, o objetivo desta tese foi avaliar os possíveis efeitos da GUO sobre as alterações agudas e crônicas causadas pelo TCE e em modelo de excitotoxicidade em roedores. O composto foi investigado em diferentes modelos experimentais e os resultados divididos em um artigo científico e dois manuscritos. Os resultados do artigo 1 demonstraram a ação neuroprotetora da GUO contra os efeitos agudos observados na cascata secundária 3h pós trauma. O desequilíbrio na atividade mitocondrial e no sistema redox caracterizados no modelo utilizado, foram reduzidos pela GUO nas diferentes estruturas cerebrais. Ao mesmo tempo, podemos notar a eficácia da GUO na manutenção da homeostase do Ca2+, também alterado pós o TCE. Este efeito evidencia a íntima relação entre a restauração da atividade mitocondrial e a manutenção do sistema glutamatérgico produzidos pela GUO. No manuscrito 1, o estudo focou-se em avaliar a relação das alterações comportamentais e morfológicas desencadeadas pelo TCE a longo prazo (durante 21 dias), bem como o potencial de ação da GUO. Em relação as comorbidades referenciadas neste modelo experimental, observamos um aumento no comportamento do tipo ansioso dos animais, acompanhado de prejuízos na capacidade cognitiva. Isso corrobora com as alterações encontradas na expressão de proteínas relacionadas aos processos de plasticidade e reparação sináptica no hipocampo. O dano tecidual caracterizado pelo aumento da morte celular, astrogliose e gliose são confirmados 21 dias após o TCE. O tratamento crônico com a GUO conferiu neuroproteção contra estes parâmetros, entretanto este efeito foi impedido pela administração de DPCPX (antagonista do receptor de adenosina A1). Isso demonstra que a GUO pode modular direta ou indiretamente o sistema adenosinérgico em situações de neuroproteção. No manuscrito 2, o estudo focou-se em avaliar possíveis alvos da ação farmacológica da GUO em um modelo de hiperexcitabilidade. Através de ferramentas eletrofisiológicas pode-se confirmar o seu efeito protetor contra as alterações na transmissão sináptica basal, intimamente associada a ação astrocitária. Percebeu-se neste mesmo sentido que as ondas de cálcio (Ca2+) e seu equilíbrio são essenciais para sua atividade, e que este equilíbrio não é exclusivamente dependente de um canal de Ca2+ ou de potássio (K+). Observou-se ainda que a GUO estabeleceu seu efeito neuprotetor provavelmente através da regulação dos níveis de adenosina e da modulação de receptores do tipo P2 (P2Y1) e não por uma ligação direta com os receptores adenosinérgicos. Desta forma, esta tese contribuiu para caracterizar o efeito neuroprotetor da GUO contra os danos agudos e crônicos causados pelo TCE bem como seus possíveis mecanismos de ação envolvidos.Universidade Federal de Santa MariaBrasilBioquímicaUFSMPrograma de Pós-Graduação em Ciências Biológicas: Bioquímica ToxicológicaCentro de Ciências Naturais e ExatasSoares, Félix Alexandre Antuneshttp://lattes.cnpq.br/8752453650114092Souza, Diogo Onofre Gomes dehttp://lattes.cnpq.br/9534019126486839Fachinetto, Roseleihttp://lattes.cnpq.br/7203076675431306Tasca, Carla Ineshttp://lattes.cnpq.br/4755946475264985Oliveira, Mauro Schneiderhttp://lattes.cnpq.br/7132934163734175Dobrachinski, Fernando2019-08-20T19:12:31Z2019-08-20T19:12:31Z2017-03-03info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17975ark:/26339/001300000jx1cporAttribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-06-13T14:54:39Zoai:repositorio.ufsm.br:1/17975Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2022-06-13T14:54:39Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false |
| dc.title.none.fl_str_mv |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico Effect of guanosine against acute and chronic damage caused by traumatic brain injury: a new perspective involving the purinergic system |
| title |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| spellingShingle |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico Dobrachinski, Fernando Traumatismo crânio encefálico Excitotoxicidade Guanosina Sistema purinérgico Avaliação comportamental Eletrofisiologia Traumatic brain injury Excitotoxicity Guanosine Purinergic system Behavioral evaluation Electrophysiology CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
| title_short |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| title_full |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| title_fullStr |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| title_full_unstemmed |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| title_sort |
Efeito da guanosina contra danos agudos e crônicos causados por trauma crânio encefálico: uma nova perspectiva envolvendo o sistema purinérgico |
| author |
Dobrachinski, Fernando |
| author_facet |
Dobrachinski, Fernando |
| author_role |
author |
| dc.contributor.none.fl_str_mv |
Soares, Félix Alexandre Antunes http://lattes.cnpq.br/8752453650114092 Souza, Diogo Onofre Gomes de http://lattes.cnpq.br/9534019126486839 Fachinetto, Roselei http://lattes.cnpq.br/7203076675431306 Tasca, Carla Ines http://lattes.cnpq.br/4755946475264985 Oliveira, Mauro Schneider http://lattes.cnpq.br/7132934163734175 |
| dc.contributor.author.fl_str_mv |
Dobrachinski, Fernando |
| dc.subject.por.fl_str_mv |
Traumatismo crânio encefálico Excitotoxicidade Guanosina Sistema purinérgico Avaliação comportamental Eletrofisiologia Traumatic brain injury Excitotoxicity Guanosine Purinergic system Behavioral evaluation Electrophysiology CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
| topic |
Traumatismo crânio encefálico Excitotoxicidade Guanosina Sistema purinérgico Avaliação comportamental Eletrofisiologia Traumatic brain injury Excitotoxicity Guanosine Purinergic system Behavioral evaluation Electrophysiology CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA |
| description |
Traumatic brain injury (TBI) is a multipathology associated to severe physiological changes that result in an unfavorable socioeconomic impact in a worldwide. Its pathophysiology comprises excitotoxicity, mitochondrial dysfunction and inflammatory processes leading to cells death in the central nervous system. Consequently, cognitive changes converge to clinical manifestations, such as behavioral deficits and the appearance of neurodegenerative processes. In experimental models of TBI many promising drugs reported failures when clinically tested, largely because of their effects on a single system. Thus, it is sought to study new therapeutic alternatives such as Guanosine (GUO), an endogenous purinergic nucleoside. At present, attention has been paid to its neuroprotective effects, since it reduces neurotoxic and degenerative events in several experimental models in vivo and in vitro. In this context, the objective of this thesis was to evaluate the possible effects of GUO on the acute and chronic alterations caused by TBI and in a model of excitotoxicity in rodents. The action of purinergic nucleoside was investigated in different experimental models and the results divided into one scientific paper and two manuscripts. The results of article 1 demonstrated the neuroprotective action of GUO against the acute effects observed in the secondary cascade 3h post-trauma. The imbalance in mitochondrial activity and the redox system in TBI model, were reduced by GUO in cerebral structures. At the same time, we can note the effectiveness of GUO in the maintenance of Ca2+ homeostasis modified after TBI. This effect reveals the relationship between the restoration of mitochondrial activity and the maintenance of the glutamatergic system produced by GUO. In manuscript 1, the study focuses on assessing the relationship of behavioral and morphological chronic changes triggered by TBI (for 21 days), as well as the potential action of GUO. Regarding the comorbidities referenced in this experimental model, we observed an increase in the anxiety-like behavior of animals, accompanied by impairments in cognitive function. Its corroborates with the alterations found in the expression of proteins related to the processes of plasticity and synaptic repair in the hippocampus. In this way, hippocampus damage is characterized by an increase of neuron cell death, astrogliosis and reactive microgliosis 21 days after TBI. Chronic treatment with GUO conferred neuroprotection against these parameters, but the A1 adenosine receptor antagonist blocked this effect. In manuscript 2, the study focused on evaluating possible targets of the pharmacological action of GUO in a model of excitotoxicity. Across electrophysiological tools, it can be confirmed the protective effect of GUO against excitotoxicity, through the astrocytic function. In this context, it was found that the homeostasis of calcium (Ca2+) is essential for its activity and this neuroprotection effect is not only dependent on the Ca2+ or potassium (K+) channel activity. Moreover, it was observed that GUO established its protective effect by regulating adenosine levels and modulating P2 (P2Y1) receptors rather than a direct binding with adenosinergic receptors. In this way, this thesis characterized the neuroprotective effect of GUO against acute and chronic damages caused by TBI as well as the possible mechanisms of action involved. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017-03-03 2019-08-20T19:12:31Z 2019-08-20T19:12:31Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
| format |
doctoralThesis |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://repositorio.ufsm.br/handle/1/17975 |
| dc.identifier.dark.fl_str_mv |
ark:/26339/001300000jx1c |
| url |
http://repositorio.ufsm.br/handle/1/17975 |
| identifier_str_mv |
ark:/26339/001300000jx1c |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Brasil Bioquímica UFSM Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica Centro de Ciências Naturais e Exatas |
| publisher.none.fl_str_mv |
Universidade Federal de Santa Maria Brasil Bioquímica UFSM Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica Centro de Ciências Naturais e Exatas |
| dc.source.none.fl_str_mv |
reponame:Manancial - Repositório Digital da UFSM instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
| instname_str |
Universidade Federal de Santa Maria (UFSM) |
| instacron_str |
UFSM |
| institution |
UFSM |
| reponame_str |
Manancial - Repositório Digital da UFSM |
| collection |
Manancial - Repositório Digital da UFSM |
| repository.name.fl_str_mv |
Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM) |
| repository.mail.fl_str_mv |
atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br |
| _version_ |
1847153410340552704 |